Spondylarthritis Clinical Trial
Official title:
Feasibility of an Il-17a Assay and Impact on Therapeutic Response in Patients With Active Axial Spondyloarthritis
There are, to date, no validated biomarkers or head-to-head RCTs of biologics to guide choice of biologic agent in axSpA. While there are now two head-to-head studies of a TNF inhibitor (TNFi) vs an IL-17 inhibitor (IL-17i) in psoriatic arthritis. Recommendations refers to biological DMARDs (bDMARDs) including TNFi and IL-17i for patients with high disease activity despite the use (or intolerance/contraindication) of at least two non-steroidal anti-inflammatory drugs (NSAIDs) in axial SpA (axSpA) and in failure of a strategy including methotrexate for psoriatic arthritis. A tool to help us to decide which bDMARDs to use is necessary. In SpA, the method of determination of IL17 seems to be questionable. The determination of cytokines after stimulation of immune cells in patients with active SpA requiring a biological treatment could provide us with a tool to assist in the choice of therapy. The aim of the study was to show the feasibility of cytokine assay following lymphocyte stimulation in active SpA requiring biological treatment. And secondly, to show the predictive character of this expression on the therapeutic response at three months after the implementation of a biological treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05494203 -
Multi-omics Study and Drug Intervention Study of Spondyloarthritis
|
||
| Completed |
NCT03818958 -
Seric Calprotectine in Spondyloarthritis
|
||
| Not yet recruiting |
NCT03940911 -
Fatigue and Skeletal Muscle Impact in Severe Axial Spondylarthritis
|
N/A | |
| Completed |
NCT01947465 -
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
|
N/A | |
| Recruiting |
NCT05926453 -
Assessment of Cardiorespiratory Fitness in Spondylarthritis
|
||
| Recruiting |
NCT05080218 -
COVID-19 VaccinE Response in Rheumatology Patients
|
Phase 4 | |
| Terminated |
NCT03454932 -
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
|
||
| Completed |
NCT01314547 -
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
|
N/A | |
| Not yet recruiting |
NCT06273306 -
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
|
N/A | |
| Recruiting |
NCT02809781 -
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
|
Phase 2/Phase 3 | |
| Completed |
NCT02098694 -
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis
|
N/A | |
| Recruiting |
NCT00491933 -
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
|
N/A | |
| Enrolling by invitation |
NCT04964661 -
Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA)
|
||
| Completed |
NCT02473315 -
Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis
|
N/A | |
| Completed |
NCT03999489 -
Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
|
||
| Recruiting |
NCT04519866 -
Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
|
N/A | |
| Completed |
NCT02402894 -
Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
|
||
| Completed |
NCT02988674 -
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
|
||
| Recruiting |
NCT05555433 -
Calprotectine in Spondyloarthritis
|
||
| Completed |
NCT01302730 -
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
|
N/A |